approvedassets

146 results found.

Top Stocks matching your search for "approved assets"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
BABA

Alibaba Group Holding Ltd - ADR

-20.42%

$105.11 - $83.65

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Nov, 19, 2022

With their Wellness Pro and their Pod, you can man... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
XRTX

XORTX Therapeutics Inc

-24.19%

$0.62 - $0.47

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

Still Bull, still confident its a great drug.

Mar, 15, 2023

$AUPH Since VOC is the only drug with any evidence... See more

BABA

Alibaba Group Holding Ltd - ADR

-20.42%

$105.11 - $83.65

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Nov, 19, 2022

With their Wellness Pro and their Pod, you can manage your pain without taking drugs.

XRTX

XORTX Therapeutics Inc

-24.19%

$0.62 - $0.47

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

Still Bull, still confident its a great drug.

Mar, 15, 2023

$AUPH Since VOC is the only drug with any evidence classified as “High”, this stock will definitely be acquired above $30+++!!!

Mar, 10, 2023

Blockbuster drug with improving sales and long patent life

Mar, 9, 2023

BP would save so many lives with this drug.

Mar, 2, 2023

1 Its approved and works great 2 Cause I see value.. IE BO GRABS 🍿

Mar, 1, 2023

The ability to spread the drug’s benefits and get patients aware of the treatment would put us in a spotlight that no other way could.

Mar, 1, 2023

• 97% gross margin (sheesh) • Excited bout new partnership(details soon) • drug price increase • 85% conversion psf's (stellar) • Tam is there, huge growth opportunity if they can get more sle patients tested, 75% would capture many.

Feb, 28, 2023

LUPKYNIS is undoubtedly the best-in-class drug to treat Lupus Nephritis.

Feb, 17, 2023

Before people start complaining about voc pricing, it’s cheaper than my drug, and life saving, whereas mine is joint sparing… What’s the bear thesis here again? ?